Ticker Details
uniQure N.V. Ordinary Shares uniQure NV is engaged in the field of gene therapy platform across three therapeutic focus areas: Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.
IPO Date:	March 1, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.36B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.77 | 3.42%
Avg Daily Range (30 D):	$1.34 | 3.16%
Avg Daily Range (90 D):	$1.38 | 4.43%

Institutional Daily Volume
Avg Daily Volume:	.72M
Avg Daily Volume (30 D):	1.15M
Avg Daily Volume (90 D):	1.7M

Trade Size
Avg Trade Size (Sh.):	92
Avg Trade Size (Sh.) (30 D):	64
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	3,532
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$2.69M
Avg Institutional Trade (90 D):	$2.71M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.26M
Avg Closing Trade (30 D):	$4.3M
Avg Closing Trade (90 D):	$4.84M
Avg Closing Volume:	104.44K

News

Jun 24, 2026 @ 1:13 AM uniQure Announces Pricing of Upsized $225 Million ... Source: Na

May 21, 2026 @ 2:30 PM Numero AI and Royu Merge to Redefine How Finance T... Source: Not Specified

Apr 13, 2026 @ 1:00 PM QURE Investors Have Opportunity to Lead uniQure N.... Source: The Schall Law Firm

Apr 10, 2026 @ 5:53 PM INVESTOR DEADLINE: uniQure (QURE) Investors with S... Source: Hagens Berman

Apr 8, 2026 @ 8:57 PM INVESTOR DEADLINE: uniQure (QURE) Investors with S... Source: Hagens Berman

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-4.03	$-1.22	$-.85
Diluted EPS	$-4.03	$-1.22	$-.85
Revenue	$18.67M	$5.84M	$3.56M
Gross Profit	$17.27M	$5.49M	$3.34M
Net Income / Loss	$-252.21M	$-81.06M	$-53.54M
Operating Income / Loss	$-200.08M	$-52.2M	$-45.72M
Cost of Revenue	$1.4M	$.35M	$.22M
Net Cash Flow	$159.29M	$273.03M	$59.74M
PE Ratio